0.3950
+0.0200
+(5.33%)
At close: 4:10:17 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
25,643.2650
25,643.2650
22,823.3430
16,956.4020
10,928.1660
Operating Income
-25,643.2650
-25,643.2650
-22,823.3430
-16,956.4020
-10,928.1660
Net Non Operating Interest Income Expense
176.0120
176.0120
36.7870
2.3680
1.5060
Other Income Expense
8,392.1700
8,392.1700
8,983.7370
6,463.4550
4,554.9260
Pretax Income
-17,075.0830
-17,075.0830
-13,802.8190
-10,490.5790
-6,371.7340
Net Income Common Stockholders
-17,075.0830
-17,075.0830
-13,802.8190
-10,490.5790
-6,371.7340
Basic EPS
-0.03
--
-0.04
-0.03
-0.03
Diluted EPS
-0.03
--
-0.04
-0.03
-0.03
Basic Average Shares
365,116.0660
--
325,529.1080
299,535.0730
201,389.6540
Diluted Average Shares
365,116.0660
--
325,529.1080
299,535.0730
201,389.6540
Net Income from Continuing & Discontinued Operation
-17,075.0830
-17,075.0830
-13,802.8190
-10,490.5790
-6,371.7340
Normalized Income
-17,075.0830
-17,075.0830
-13,802.8190
-10,490.5790
-6,371.7340
Interest Income
176.0120
176.0120
36.7870
2.3680
1.5060
Net Interest Income
176.0120
176.0120
36.7870
2.3680
1.5060
EBIT
-25,643.2650
-25,643.2650
-22,823.3430
-16,956.4020
-10,928.1660
EBITDA
-25,594.5170
-25,594.5170
-22,767.3340
-16,905.8570
-10,883.5650
Reconciled Depreciation
48.7480
48.7480
56.0090
50.5450
44.6010
Net Income from Continuing Operation Net Minority Interest
-17,075.0830
-17,075.0830
-13,802.8190
-10,490.5790
-6,371.7340
Normalized EBITDA
-25,594.5170
-25,594.5170
-22,767.3340
-16,905.8570
-10,883.5650
6/30/2021 - 7/31/1989
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AGN.AX Argenica Therapeutics Limited
0.7250
+8.21%
PAR.AX Paradigm Biopharmaceuticals Limited
0.2900
-4.92%
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%
NUZ.AX Neurizon Therapeutics Limited
0.1050
+6.06%
BIT.AX Biotron Limited
0.0020
-33.33%
PTX.AX Prescient Therapeutics Limited
0.0420
+2.44%
ACW.AX Actinogen Medical Limited
0.0300
+7.14%
ACR.AX Acrux Limited
0.0240
+9.09%
CYP.AX Cynata Therapeutics Limited
0.1900
-2.56%
RAC.AX Race Oncology Limited
1.0200
-0.97%